Clinical

Dataset Information

0

The mCRC Patients With pMMR/MSS or dMMR/MSI-H Status Received Palliative Chemotherapy Efficacy and Survival


ABSTRACT: Deficient mismatch repair (dMMR) or microsatellite instability high (MSI-H) accounts for 4-5% in metastatic colorectal cancer (mCRC). The efficacy and survival of patients with dMMR/MSI-H status received palliative chemotherapy have not clear yet. In this study, the investigators observed the efficacy and survival of dMMR/MSI-H status mCRC patients received palliative first-line chemotherapy.

DISEASE(S): Microsatellite Instability High,Microsatellite Instability,Colorectal Cancer Metastatic,Colorectal Neoplasms,Mismatch Repair Deficiency

PROVIDER: 2346468 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2021-04-07 | GSE149206 | GEO
| 2303741 | ecrin-mdr-crc
| 2729957 | ecrin-mdr-crc
2021-07-19 | GSE178706 | GEO
2023-06-01 | GSE211221 | GEO
2023-06-01 | GSE210018 | GEO
2020-03-13 | GSE146889 | GEO
| 2310012 | ecrin-mdr-crc
| 2375994 | ecrin-mdr-crc
| PRJNA627657 | ENA